Skip to content
VisionGate Logo
  • Home
  • About
    • Our Team
  • Our Technology
    • Non-Intrusive Testing
    • Patented Cell-CT Imaging
    • AI Powered Detection
  • News
  • Patents
  • Publications
  • Contact

Blog

  • NewsFPO
  • Patents
  • PublicationsFPO
  • August 30, 2022

    #11,428,692:
    SPECIMEN ENRICHMENT FOR OPTICAL TOMOGRAPHY CELL ANALYSIS

    More Information

    Patents

  • August 6, 2022

    VisionGate Presents at the World Conference on Lung Cancer for 2022 in Vienna: New Assay for Smoking Status Based on 3D Imaging of Pulmonary Macrophages

    More Information

    Publications

  • September 22, 2021

    VisionGate’s New Website Illustrates its Mission to Save Lives through Early Detection of Lung Cancer

    More Information

    News

  • September 8, 2021

    VisionGate Presents at the World Conference on Lung Cancer for 2021: Non-Intrusive LuCED® Test for Detection of Early-Stage Lung Cancer: Subgroup Analysis for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    More Information

    Publications

  • July 20, 2021

    #11,069,054:
    SYSTEM AND METHOD FOR AUTOMATED DETECTION AND MONITORING OF DYSPLASIA AND ADMINISTRATION OF CHEMOPREVENTION

    More Information

    Patents

  • January 28, 2021

    VisionGate Presents at the World Conference on Lung Cancer for 2020: LuCED® Sputum Test for Assessment of Lung Cancer Risk in COPD Patients: Sensitivity and Specimen Satisfactory Rate

    More Information

    Publications

  • January 12, 2021

    #10,890,595:
    METHOD AND APPARATUS FOR PRE-POSITIONING A RADIALLY SYMMETRIC, COAXIAL SAMPLE WITHIN A SHEATH FLUID TO PROVIDE UNIFORM SAMPLE DELIVERY RATE DURING FLOW

    More Information

    Patents

  • November 12, 2020

    Patients FAQ’s

    More Information

    News

  • August 25, 2020

    #10,753,857:
    APPARATUS AND METHOD FOR MEASURING MICROSCOPIC OBJECT VELOCITIES IN FLOW

    More Information

    Patents

  • September 28, 2018

    VisionGate Presents at the 2018 conference of the American Thoracic Society: Positive Rate Of The Lung Cell Evaluation (LuCED) Test For Patients With Chronic Obstructive Pulmonary Disease (COPD)

    More Information

    Publications

Previous234Next

Follow Us

x icon
  • Home
  • About
  • Our Technology
Contact

© Copyright 2005 – 2026 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

3 Questions to Assess Your Risk

 Early detection of lung cancer is important to keeping you healthy and living your life to the fullest.

Has a family member had Lung Cancer? *
Have you smoked or been exposed to secondhand smoke? *

If you are over the age of 60 or answer "Yes" to any of the questions above, you may be at an increased risk.

This test is not a diagnosis but can help you recognize factors that may increase your risk of developing lung cancer. Next, You can subscribe to learn more from VisionGate. Then, you'll be redirected to a page of resources that can aid you in discussions with your doctor, or click here to access the page directly.

If you are above the age of 50 and answered "Yes" to any of the questions, you may be at an increased risk of developing lung cancer, but this is not a diagnosis. Use the link below to download resources that can help you talk to your doctor. Click Here to Download
We're sorry! There was an error submitting the test. Please try again later.

*No personal information is collected or saved through this form without your consent. Only your email and name will be saved if you opt-in.

visiongate logo
Contact
  • Home
  • About
  • Our Technology

© Copyright 2005 – 2026 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

Page load link
Go to Top